Titre : Amidohydrolases

Amidohydrolases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Time and Motion Studies

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une déficience en amidohydrolases ?

Des tests enzymatiques et des analyses génétiques peuvent être effectués.
Déficience enzymatique Tests diagnostiques
#2

Quels tests sanguins sont utilisés pour évaluer les amidohydrolases ?

Les dosages enzymatiques dans le sérum peuvent indiquer l'activité des amidohydrolases.
Tests sanguins Amidohydrolases
#3

Les biopsies sont-elles nécessaires pour le diagnostic ?

Dans certains cas, des biopsies peuvent être nécessaires pour évaluer l'activité enzymatique.
Biopsie Diagnostic
#4

Quels symptômes peuvent indiquer un problème d'amidohydrolases ?

Des troubles digestifs ou métaboliques peuvent signaler une anomalie enzymatique.
Symptômes Troubles métaboliques
#5

Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?

L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées.
Imagerie médicale Complications

Symptômes 5

#1

Quels sont les symptômes d'une déficience en amidohydrolases ?

Les symptômes incluent des douleurs abdominales, des ballonnements et des troubles digestifs.
Déficience enzymatique Symptômes
#2

Les troubles métaboliques sont-ils liés aux amidohydrolases ?

Oui, une activité enzymatique anormale peut entraîner divers troubles métaboliques.
Troubles métaboliques Amidohydrolases
#3

Y a-t-il des signes cutanés associés aux troubles enzymatiques ?

Des éruptions cutanées peuvent survenir en raison de déséquilibres métaboliques.
Signes cutanés Troubles enzymatiques
#4

Les symptômes varient-ils selon le type d'amidohydrolase ?

Oui, les symptômes peuvent varier en fonction de l'enzyme spécifique impliquée.
Variabilité des symptômes Amidohydrolases
#5

Les symptômes sont-ils immédiats ou progressifs ?

Ils peuvent être progressifs, se développant avec le temps en fonction de la déficience.
Symptômes progressifs Déficience enzymatique

Prévention 5

#1

Peut-on prévenir les troubles liés aux amidohydrolases ?

La prévention est difficile, mais un mode de vie sain peut réduire les risques.
Prévention Mode de vie sain
#2

Les tests génétiques peuvent-ils aider à la prévention ?

Oui, les tests génétiques peuvent identifier les personnes à risque de déficiences enzymatiques.
Tests génétiques Prévention
#3

Une alimentation équilibrée peut-elle prévenir ces troubles ?

Une alimentation équilibrée peut soutenir la santé enzymatique, mais ne garantit pas la prévention.
Alimentation équilibrée Santé enzymatique
#4

Les vaccinations ont-elles un rôle dans la prévention ?

Les vaccinations ne sont pas directement liées à la prévention des troubles enzymatiques.
Vaccinations Prévention
#5

L'éducation sur les maladies héréditaires est-elle importante ?

Oui, l'éducation peut aider les familles à comprendre et à gérer les risques associés.
Éducation Maladies héréditaires

Traitements 5

#1

Quels traitements existent pour les déficiences en amidohydrolases ?

Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques.
Traitements Suppléments enzymatiques
#2

Les médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?

Certains médicaments peuvent moduler l'activité enzymatique, mais leur efficacité varie.
Médicaments Amidohydrolases
#3

La thérapie génique est-elle une option pour ces troubles ?

La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles.
Thérapie génique Troubles enzymatiques
#4

Les changements alimentaires peuvent-ils améliorer les symptômes ?

Oui, une alimentation adaptée peut aider à gérer les symptômes liés aux déficiences enzymatiques.
Changements alimentaires Gestion des symptômes
#5

Y a-t-il des traitements naturels pour les troubles d'amidohydrolases ?

Certaines approches naturelles peuvent aider, mais il est essentiel de consulter un médecin.
Traitements naturels Consultation médicale

Complications 5

#1

Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?

Des complications digestives, métaboliques et neurologiques peuvent se développer.
Complications Troubles digestifs
#2

Les troubles d'amidohydrolases peuvent-ils affecter la croissance ?

Oui, des déficiences enzymatiques peuvent entraîner des retards de croissance chez les enfants.
Retards de croissance Déficiences enzymatiques
#3

Y a-t-il des risques de maladies auto-immunes ?

Certaines études suggèrent un lien entre les troubles enzymatiques et les maladies auto-immunes.
Maladies auto-immunes Troubles enzymatiques
#4

Les complications sont-elles réversibles ?

Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes.
Complications réversibles Gestion des symptômes
#5

Comment surveiller les complications potentielles ?

Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications.
Surveillance Professionnels de santé

Facteurs de risque 5

#1

Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?

Les facteurs incluent des antécédents familiaux, des maladies génétiques et des régimes alimentaires déséquilibrés.
Facteurs de risque Antécédents familiaux
#2

L'âge influence-t-il le risque de troubles enzymatiques ?

Oui, certains troubles enzymatiques se manifestent plus fréquemment à des âges spécifiques.
Âge Troubles enzymatiques
#3

Les maladies métaboliques augmentent-elles le risque ?

Oui, les maladies métaboliques peuvent prédisposer à des déficiences en amidohydrolases.
Maladies métaboliques Déficiences enzymatiques
#4

Le mode de vie peut-il influencer le risque ?

Un mode de vie malsain, incluant une mauvaise alimentation, peut augmenter le risque.
Mode de vie Risque
#5

Les facteurs environnementaux jouent-ils un rôle ?

Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes liés aux amidohydrolases.
Facteurs environnementaux Expression génétique
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Amidohydrolases : Questions médicales les plus fréquentes", "headline": "Amidohydrolases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Amidohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-19", "dateModified": "2025-03-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Amidohydrolases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hydrolases", "url": "https://questionsmedicales.fr/mesh/D006867", "about": { "@type": "MedicalCondition", "name": "Hydrolases", "code": { "@type": "MedicalCode", "code": "D006867", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "N-acetylmuramoyl-l-alanine amidase", "alternateName": "N-Acetylmuramoyl-L-alanine Amidase", "url": "https://questionsmedicales.fr/mesh/D009238", "about": { "@type": "MedicalCondition", "name": "N-acetylmuramoyl-l-alanine amidase", "code": { "@type": "MedicalCode", "code": "D009238", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.030" } } }, { "@type": "MedicalWebPage", "name": "Allophanate hydrolase", "alternateName": "Allophanate Hydrolase", "url": "https://questionsmedicales.fr/mesh/D000492", "about": { "@type": "MedicalCondition", "name": "Allophanate hydrolase", "code": { "@type": "MedicalCode", "code": "D000492", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.060" } } }, { "@type": "MedicalWebPage", "name": "Formamidase", "alternateName": "Arylformamidase", "url": "https://questionsmedicales.fr/mesh/D005558", "about": { "@type": "MedicalCondition", "name": "Formamidase", "code": { "@type": "MedicalCode", "code": "D005558", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.100" } } }, { "@type": "MedicalWebPage", "name": "Asparaginase", "alternateName": "Asparaginase", "url": "https://questionsmedicales.fr/mesh/D001215", "about": { "@type": "MedicalCondition", "name": "Asparaginase", "code": { "@type": "MedicalCode", "code": "D001215", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.116" } } }, { "@type": "MedicalWebPage", "name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase", "alternateName": "Aspartylglucosylaminase", "url": "https://questionsmedicales.fr/mesh/D001227", "about": { "@type": "MedicalCondition", "name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase", "code": { "@type": "MedicalCode", "code": "D001227", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.125" } } }, { "@type": "MedicalWebPage", "name": "bêta-Lactamases", "alternateName": "beta-Lactamases", "url": "https://questionsmedicales.fr/mesh/D001618", "about": { "@type": "MedicalCondition", "name": "bêta-Lactamases", "code": { "@type": "MedicalCode", "code": "D001618", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cephalosporinase", "alternateName": "Cephalosporinase", "url": "https://questionsmedicales.fr/mesh/D002510", "about": { "@type": "MedicalCondition", "name": "Cephalosporinase", "code": { "@type": "MedicalCode", "code": "D002510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180.229" } } }, { "@type": "MedicalWebPage", "name": "Penicillinase", "alternateName": "Penicillinase", "url": "https://questionsmedicales.fr/mesh/D010405", "about": { "@type": "MedicalCondition", "name": "Penicillinase", "code": { "@type": "MedicalCode", "code": "D010405", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180.697" } } } ] }, { "@type": "MedicalWebPage", "name": "Biotinidase", "alternateName": "Biotinidase", "url": "https://questionsmedicales.fr/mesh/D043523", "about": { "@type": "MedicalCondition", "name": "Biotinidase", "code": { "@type": "MedicalCode", "code": "D043523", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.200" } } }, { "@type": "MedicalWebPage", "name": "Ceramidases", "alternateName": "Ceramidases", "url": "https://questionsmedicales.fr/mesh/D055572", "about": { "@type": "MedicalCondition", "name": "Ceramidases", "code": { "@type": "MedicalCode", "code": "D055572", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acid Ceramidase", "alternateName": "Acid Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055573", "about": { "@type": "MedicalCondition", "name": "Acid Ceramidase", "code": { "@type": "MedicalCode", "code": "D055573", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.100" } } }, { "@type": "MedicalWebPage", "name": "Alkaline Ceramidase", "alternateName": "Alkaline Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055574", "about": { "@type": "MedicalCondition", "name": "Alkaline Ceramidase", "code": { "@type": "MedicalCode", "code": "D055574", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.300" } } }, { "@type": "MedicalWebPage", "name": "Neutral Ceramidase", "alternateName": "Neutral Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055576", "about": { "@type": "MedicalCondition", "name": "Neutral Ceramidase", "code": { "@type": "MedicalCode", "code": "D055576", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.650" } } } ] }, { "@type": "MedicalWebPage", "name": "Dihydro-orotase", "alternateName": "Dihydroorotase", "url": "https://questionsmedicales.fr/mesh/D004080", "about": { "@type": "MedicalCondition", "name": "Dihydro-orotase", "code": { "@type": "MedicalCode", "code": "D004080", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.280" } } }, { "@type": "MedicalWebPage", "name": "Glutaminase", "alternateName": "Glutaminase", "url": "https://questionsmedicales.fr/mesh/D005972", "about": { "@type": "MedicalCondition", "name": "Glutaminase", "code": { "@type": "MedicalCode", "code": "D005972", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.483" } } }, { "@type": "MedicalWebPage", "name": "Histone deacetylases", "alternateName": "Histone Deacetylases", "url": "https://questionsmedicales.fr/mesh/D006655", "about": { "@type": "MedicalCondition", "name": "Histone deacetylases", "code": { "@type": "MedicalCode", "code": "D006655", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Group III Histone Deacetylases", "alternateName": "Group III Histone Deacetylases", "url": "https://questionsmedicales.fr/mesh/D056545", "about": { "@type": "MedicalCondition", "name": "Group III Histone Deacetylases", "code": { "@type": "MedicalCode", "code": "D056545", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520.200" } } }, { "@type": "MedicalWebPage", "name": "Histone deacetylase 6", "alternateName": "Histone Deacetylase 6", "url": "https://questionsmedicales.fr/mesh/D000073864", "about": { "@type": "MedicalCondition", "name": "Histone deacetylase 6", "code": { "@type": "MedicalCode", "code": "D000073864", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520.350" } } } ] }, { "@type": "MedicalWebPage", "name": "Nicotinamidase", "alternateName": "Nicotinamidase", "url": "https://questionsmedicales.fr/mesh/D009535", "about": { "@type": "MedicalCondition", "name": "Nicotinamidase", "code": { "@type": "MedicalCode", "code": "D009535", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.610" } } }, { "@type": "MedicalWebPage", "name": "Penicillin amidase", "alternateName": "Penicillin Amidase", "url": "https://questionsmedicales.fr/mesh/D010399", "about": { "@type": "MedicalCondition", "name": "Penicillin amidase", "code": { "@type": "MedicalCode", "code": "D010399", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.690" } } }, { "@type": "MedicalWebPage", "name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase", "alternateName": "Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase", "url": "https://questionsmedicales.fr/mesh/D043524", "about": { "@type": "MedicalCondition", "name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase", "code": { "@type": "MedicalCode", "code": "D043524", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.725" } } }, { "@type": "MedicalWebPage", "name": "5-Oxoprolinase(ATP-hydrolysing)", "alternateName": "Pyroglutamate Hydrolase", "url": "https://questionsmedicales.fr/mesh/D011752", "about": { "@type": "MedicalCondition", "name": "5-Oxoprolinase(ATP-hydrolysing)", "code": { "@type": "MedicalCode", "code": "D011752", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.760" } } }, { "@type": "MedicalWebPage", "name": "Urease", "alternateName": "Urease", "url": "https://questionsmedicales.fr/mesh/D014510", "about": { "@type": "MedicalCondition", "name": "Urease", "code": { "@type": "MedicalCode", "code": "D014510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.902" } } } ], "about": { "@type": "MedicalCondition", "name": "Amidohydrolases", "alternateName": "Amidohydrolases", "code": { "@type": "MedicalCode", "code": "D000581", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Rolandas Meškys", "url": "https://questionsmedicales.fr/author/Rolandas%20Me%C5%A1kys", "affiliation": { "@type": "Organization", "name": "Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania." } }, { "@type": "Person", "name": "Yumei Hu", "url": "https://questionsmedicales.fr/author/Yumei%20Hu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } }, { "@type": "Person", "name": "Longhai Dai", "url": "https://questionsmedicales.fr/author/Longhai%20Dai", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Sinofn (Tianjin) Pharmaceutical Technology Co., Ltd, Tianjin 300308, PR China." } }, { "@type": "Person", "name": "Du Niu", "url": "https://questionsmedicales.fr/author/Du%20Niu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } }, { "@type": "Person", "name": "Zhenzhen Xie", "url": "https://questionsmedicales.fr/author/Zhenzhen%20Xie", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Analysis of home care nurses' workload: A time-motion study.", "datePublished": "2023-04-16", "url": "https://questionsmedicales.fr/article/37061940", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/01621424.2023.2202149" } }, { "@type": "ScholarlyArticle", "name": "The Time, Places, and Activities of Nurses in a Psychiatric Inpatient Context - A Time and Motion Study with a Time-geographic Perspective.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37126738", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/01612840.2023.2194990" } }, { "@type": "ScholarlyArticle", "name": "Activities of the oral health teams in primary health care: a time-motion study.", "datePublished": "2024-05-10", "url": "https://questionsmedicales.fr/article/38730416", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-024-11053-5" } }, { "@type": "ScholarlyArticle", "name": "Understanding the workflow of nurses in acute and subacute medical wards: A time and motion study.", "datePublished": "2023-07-25", "url": "https://questionsmedicales.fr/article/37489643", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jocn.16835" } }, { "@type": "ScholarlyArticle", "name": "A time motion study of manual versus artificial intelligence methods for wound assessment.", "datePublished": "2022-07-28", "url": "https://questionsmedicales.fr/article/35901189", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0271742" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Hydrolases", "item": "https://questionsmedicales.fr/mesh/D006867" }, { "@type": "ListItem", "position": 5, "name": "Amidohydrolases", "item": "https://questionsmedicales.fr/mesh/D000581" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Amidohydrolases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Amidohydrolases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Amidohydrolases", "description": "Comment diagnostiquer une déficience en amidohydrolases ?\nQuels tests sanguins sont utilisés pour évaluer les amidohydrolases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème d'amidohydrolases ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Time+and+Motion+Studies#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Amidohydrolases", "description": "Quels sont les symptômes d'une déficience en amidohydrolases ?\nLes troubles métaboliques sont-ils liés aux amidohydrolases ?\nY a-t-il des signes cutanés associés aux troubles enzymatiques ?\nLes symptômes varient-ils selon le type d'amidohydrolase ?\nLes symptômes sont-ils immédiats ou progressifs ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Time+and+Motion+Studies#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Amidohydrolases", "description": "Peut-on prévenir les troubles liés aux amidohydrolases ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nUne alimentation équilibrée peut-elle prévenir ces troubles ?\nLes vaccinations ont-elles un rôle dans la prévention ?\nL'éducation sur les maladies héréditaires est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Time+and+Motion+Studies#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Amidohydrolases", "description": "Quels traitements existent pour les déficiences en amidohydrolases ?\nLes médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?\nLa thérapie génique est-elle une option pour ces troubles ?\nLes changements alimentaires peuvent-ils améliorer les symptômes ?\nY a-t-il des traitements naturels pour les troubles d'amidohydrolases ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Time+and+Motion+Studies#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Amidohydrolases", "description": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?\nLes troubles d'amidohydrolases peuvent-ils affecter la croissance ?\nY a-t-il des risques de maladies auto-immunes ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Time+and+Motion+Studies#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Amidohydrolases", "description": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?\nL'âge influence-t-il le risque de troubles enzymatiques ?\nLes maladies métaboliques augmentent-elles le risque ?\nLe mode de vie peut-il influencer le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Time+and+Motion+Studies#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en amidohydrolases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses génétiques peuvent être effectués." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés pour évaluer les amidohydrolases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les dosages enzymatiques dans le sérum peuvent indiquer l'activité des amidohydrolases." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, des biopsies peuvent être nécessaires pour évaluer l'activité enzymatique." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème d'amidohydrolases ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles digestifs ou métaboliques peuvent signaler une anomalie enzymatique." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en amidohydrolases ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des ballonnements et des troubles digestifs." } }, { "@type": "Question", "name": "Les troubles métaboliques sont-ils liés aux amidohydrolases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une activité enzymatique anormale peut entraîner divers troubles métaboliques." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés aux troubles enzymatiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent survenir en raison de déséquilibres métaboliques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type d'amidohydrolase ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'enzyme spécifique impliquée." } }, { "@type": "Question", "name": "Les symptômes sont-ils immédiats ou progressifs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être progressifs, se développant avec le temps en fonction de la déficience." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés aux amidohydrolases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils aider à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les personnes à risque de déficiences enzymatiques." } }, { "@type": "Question", "name": "Une alimentation équilibrée peut-elle prévenir ces troubles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé enzymatique, mais ne garantit pas la prévention." } }, { "@type": "Question", "name": "Les vaccinations ont-elles un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne sont pas directement liées à la prévention des troubles enzymatiques." } }, { "@type": "Question", "name": "L'éducation sur les maladies héréditaires est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation peut aider les familles à comprendre et à gérer les risques associés." } }, { "@type": "Question", "name": "Quels traitements existent pour les déficiences en amidohydrolases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent moduler l'activité enzymatique, mais leur efficacité varie." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour ces troubles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles." } }, { "@type": "Question", "name": "Les changements alimentaires peuvent-ils améliorer les symptômes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation adaptée peut aider à gérer les symptômes liés aux déficiences enzymatiques." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour les troubles d'amidohydrolases ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines approches naturelles peuvent aider, mais il est essentiel de consulter un médecin." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications digestives, métaboliques et neurologiques peuvent se développer." } }, { "@type": "Question", "name": "Les troubles d'amidohydrolases peuvent-ils affecter la croissance ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déficiences enzymatiques peuvent entraîner des retards de croissance chez les enfants." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies auto-immunes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre les troubles enzymatiques et les maladies auto-immunes." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications potentielles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies génétiques et des régimes alimentaires déséquilibrés." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de troubles enzymatiques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles enzymatiques se manifestent plus fréquemment à des âges spécifiques." } }, { "@type": "Question", "name": "Les maladies métaboliques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies métaboliques peuvent prédisposer à des déficiences en amidohydrolases." } }, { "@type": "Question", "name": "Le mode de vie peut-il influencer le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie malsain, incluant une mauvaise alimentation, peut augmenter le risque." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes liés aux amidohydrolases." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 16/03/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

23 au total
└─

N-acetylmuramoyl-l-alanine amidase

N-Acetylmuramoyl-L-alanine Amidase D009238 - D08.811.277.087.030
└─

Allophanate hydrolase

Allophanate Hydrolase D000492 - D08.811.277.087.060
└─

Formamidase

Arylformamidase D005558 - D08.811.277.087.100
└─

Asparaginase

Asparaginase D001215 - D08.811.277.087.116
└─

N4-(beta-N-acetylglucosaminyl)-L-asparaginase

Aspartylglucosylaminase D001227 - D08.811.277.087.125
└─

bêta-Lactamases

beta-Lactamases D001618 - D08.811.277.087.180
└─

Biotinidase

Biotinidase D043523 - D08.811.277.087.200
└─

Ceramidases

Ceramidases D055572 - D08.811.277.087.250
└─

Dihydro-orotase

Dihydroorotase D004080 - D08.811.277.087.280
└─

Glutaminase

Glutaminase D005972 - D08.811.277.087.483
└─

Histone deacetylases

Histone Deacetylases D006655 - D08.811.277.087.520
└─

Nicotinamidase

Nicotinamidase D009535 - D08.811.277.087.610
└─

Penicillin amidase

Penicillin Amidase D010399 - D08.811.277.087.690
└─

Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase

Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase D043524 - D08.811.277.087.725
└─

5-Oxoprolinase(ATP-hydrolysing)

Pyroglutamate Hydrolase D011752 - D08.811.277.087.760
└─

Urease

Urease D014510 - D08.811.277.087.902
└─└─

Cephalosporinase

Cephalosporinase D002510 - D08.811.277.087.180.229
└─└─

Penicillinase

Penicillinase D010405 - D08.811.277.087.180.697
└─└─

Acid Ceramidase

Acid Ceramidase D055573 - D08.811.277.087.250.100
└─└─

Alkaline Ceramidase

Alkaline Ceramidase D055574 - D08.811.277.087.250.300
└─└─

Neutral Ceramidase

Neutral Ceramidase D055576 - D08.811.277.087.250.650
└─└─

Group III Histone Deacetylases

Group III Histone Deacetylases D056545 - D08.811.277.087.520.200
└─└─

Histone deacetylase 6

Histone Deacetylase 6 D000073864 - D08.811.277.087.520.350

Auteurs principaux

Rolandas Meškys

3 publications dans cette catégorie

Affiliations :
  • Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.

Yumei Hu

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Longhai Dai

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Sinofn (Tianjin) Pharmaceutical Technology Co., Ltd, Tianjin 300308, PR China.
Publications dans "Amidohydrolases" :

Du Niu

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Zhenzhen Xie

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Panpan Shen

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Xian Li

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Hao Li

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Jian Min

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China.
Publications dans "Amidohydrolases" :

Rey-Ting Guo

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Zhejiang Key Laboratory of Medical Epigenetics, Department of Immunology and Pathogen Biology, School of Basic Medical Sciences, Hangzhou Normal University, 311121 Hangzhou, PR China.
Publications dans "Amidohydrolases" :

Chun-Chi Chen

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Zhejiang Key Laboratory of Medical Epigenetics, Department of Immunology and Pathogen Biology, School of Basic Medical Sciences, Hangzhou Normal University, 311121 Hangzhou, PR China. Electronic address: ccckate0722@hubu.edu.cn.
Publications dans "Amidohydrolases" :

Agota Aučynaitė

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Joanna I Loch

2 publications dans cette catégorie

Affiliations :
  • Department of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Krakow, Poland.

Mariusz Jaskolski

2 publications dans cette catégorie

Affiliations :
  • Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
  • Department of Crystallography, Faculty of Chemistry, Adam Mickiewicz University, Poznan, Poland.

Roberta Statkevičiūtė

1 publication dans cette catégorie

Affiliations :
  • Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.
Publications dans "Amidohydrolases" :

Mikas Sadauskas

1 publication dans cette catégorie

Affiliations :
  • Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.
Publications dans "Amidohydrolases" :

Juta Rainytė

1 publication dans cette catégorie

Affiliations :
  • Department of Eukaryote Gene Engineering, Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.
Publications dans "Amidohydrolases" :

Karolina Kavaliauskaitė

1 publication dans cette catégorie

Affiliations :
  • Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania.
Publications dans "Amidohydrolases" :

Markus R Busch

1 publication dans cette catégorie

Affiliations :
  • Institute of Biophysics and Physical Biochemistry, Regensburg Center for Biochemistry, University of Regensburg, D-93040 Regensburg, Germany.
Publications dans "Amidohydrolases" :

Chitra Rajendran

1 publication dans cette catégorie

Affiliations :
  • Institute of Biophysics and Physical Biochemistry, Regensburg Center for Biochemistry, University of Regensburg, D-93040 Regensburg, Germany.
Publications dans "Amidohydrolases" :

Sources (10000 au total)

Activities of the oral health teams in primary health care: a time-motion study.

Efficient planning of the oral health workforce in Primary Health Care (PHC) is paramount to ensure equitable community access to services. This requires a meticulous examination of the population's n... Calculate the average time parameters for the activities carried out by the oral health team in primary health care.... This is a descriptive observational study using the time-motion method carried out in five Primary Health Care Units in the city of São Paulo, SP, Brazil. Direct and continuous observation of oral hea... A total of 696.05 h of observation were conducted with 12 Dentists, three Oral Health Assistants, and five Oral Health Technicians. The Dentists' main activity was consultation with an average duratio... The study establishes time standards for the activities performed by the dental care team and provides support for the application of workforce planning methods that allow for review and optimization ...

Understanding the workflow of nurses in acute and subacute medical wards: A time and motion study.

The aim of this study was to determine how much time nurses spend on direct and indirect patient care in acute and subacute hospital settings.... Quantifying direct and indirect nursing care provided during inpatient stay is vital to optimise the quality of care and manage resources.... Time and motion cross-sectional observational study and reported the study according to the STROBE guideline.... Nurses working in an acute or subacute medical wards of a single health service participated. Nurses were observed twice for 2 h on the same day with an observer break in between sessions. Real-time t... Twenty-one nurses (acute n = 12, subacute n = 9) were observed during shifts between 7 AM and 9 PM in May-July 2021. A total of 7240 tasks were recorded. Nurses spent a third of their time on direct p... Time spent on tasks was similar regardless of the setting and was consistent with previous research. We found differences in the distribution of tasks throughout the day between settings, which could ...

A time motion study of manual versus artificial intelligence methods for wound assessment.

This time-motion study explored the amount of time clinicians spent on wound assessments in a real-world environment using wound assessment digital application utilizing Artificial Intelligence (AI) v... Clinicians practicing at Valley Wound Center who agreed to join the study were asked to record the time needed to complete wound assessment activities for patients with active wounds referred for a ro... A total of 91 patients with 115 wounds were assessed. The average time to capture and access wound image with the AI digital tool was significantly faster than a standard digital camera with an averag... Using the digital assessment tool saved significant time for clinicians in assessing wounds. It also successfully captured quality wound images at the first attempt....

Impact of school-based malaria intervention on primary school teachers' time in Malawi: evidence from a time and motion study.

School-based health (SBH) programmes that are contingent on primary school teachers are options to increase access to malaria treatment among learners. However, perceptions that provision of healthcar... A time and motion study was conducted in 10 primary schools in rural Malawi. Teachers who had been trained to diagnose and treat uncomplicated malaria were continuously observed in real time during sc... Seventy-four teachers, trained to use LTK, were observed. Their mean age and years of teaching experience were 34.7 and 8.7, respectively. Overall, 739.8 h of teacher observations took place. The aver... School-based health (SBH) programmes are not detrimental to teaching activities. Teachers manage their time to ensure additional time required for SBH services is not at the expense of teaching duties...

Assessing community health workers' time allocation for a cervical cancer screening and treatment intervention in Malawi: a time and motion study.

Community health workers (CHWs) are essential field-based personnel and increasingly used to deliver priority interventions to achieve universal health coverage. Existing literature allude to the pote... A time and motion study was conducted in 7 health facilities in Malawi. Data was collected at baseline between October-July 2019, and 12 months after CCSPT implementation between July and August 2021.... Thirty-seven (n = 37) CHWs were observed. Their mean age and years of experience were 42 and 17, respectively. Overall, CHWs were observed for 323 hours (inter quartile range: 2.8-5.5). Compared with ... Introduction of CCSPT was not very detrimental to pre-existing community services. CHWs managed their time ensuring additional efforts required for CCSPT were not at the expense of essential activitie...

Determinants of received care time among Finnish home care clients and assisted living facility residents: a time-motion study.

Ageing populations and care workforce shortages across Europe are causing challenges for care services for older people. Therefore, it is paramount that limited care resources are allocated optimally,... Cross-sectional observational study design with data from time and motion study, registers, and surveys was used. In total, 1477 home care clients and 1538 residents from assisted living facilities wi... Physical functioning was the strongest predictor of received care time in both care settings. In home care, greater pain, more unstable health, and higher team autonomy were associated with increased ... Physical functioning was the main driver of received care time. Interventions that maintain or improve physical functioning can help restrain the growing need of care resources, although it is importa...

Time-motion analysis of taekwondo matches in the Tokyo 2020 Olympic Games.

The aim of the present study was to determine the time-motion structure of high-level taekwondo matches during the Tokyo 2020 Olympic Games in relation to sex, match outcome, weight category and match... Overall, 7007 actions were recorded during the analysis of 134 performances (67 rounds of 24 matches: four rounds of 16, eight quarterfinals, eight semifinals and four finals) in male and female flywe... The AT/ST ratio was ~1:1.5. Male athletes performed significantly longer (P<0.001) sum PT than female athletes. Flyweight athletes differed significantly from their heavyweight counterparts by having ... The rule changes and the implementation of the electronic score recording system had a major impact on the time-motion structure of combat by generating a considerably higher AT/ST ratio than in the p...

Electronic oral health surveillance system for Egyptian preschoolers using District Health Information System (DHIS2): design description and time motion study.

Early childhood caries (ECC) is a major global health issue affecting millions of children. Mitigating this problem requires up-to-date information from reliable surveillance systems. This enables evi... The DHIS2 Server was configured for the DHIS2 Tracker Android Capture App to allow individual-level data entry. The EOHSS indicators were selected in line with the WHO Action Plan 2030. Two modalities... The pilot team reported positive feedback on the structure of the EOHSS. Workflow adaptations were made to prioritize surveillance tasks by collecting data from caregivers before acquiring clinical da... The DHIS2 provides a feasible solution for developing electronic, oral health surveillance systems. The one-minute difference in data capture time in telemodality compared to face-to-face indicates th...